Melanoma cell adhesion molecule is the driving force behind the dissemination of melanoma upon S100A8/A9 binding in the original skin lesion.
Animals
CD146 Antigen
/ metabolism
Calgranulin A
/ genetics
Calgranulin B
/ genetics
Cell Line, Tumor
Cell Movement
Cell Proliferation
GPI-Linked Proteins
/ metabolism
HEK293 Cells
Humans
Keratinocytes
/ pathology
Lung Neoplasms
/ secondary
MAP Kinase Kinase Kinases
/ metabolism
Matrix Metalloproteinases, Membrane-Associated
/ metabolism
Melanoma
/ pathology
Melanoma, Experimental
/ pathology
Mice
Mice, Inbred BALB C
Proto-Oncogene Proteins
/ metabolism
Proto-Oncogene Proteins c-ets
/ metabolism
RNA Interference
RNA, Small Interfering
/ genetics
Skin
/ pathology
Skin Neoplasms
/ pathology
Xenograft Model Antitumor Assays
Melanoma, Cutaneous Malignant
Inflammation
Matrix metalloproteinase
Metastasis
S100 protein
Seed and soil hypothesis
Journal
Cancer letters
ISSN: 1872-7980
Titre abrégé: Cancer Lett
Pays: Ireland
ID NLM: 7600053
Informations de publication
Date de publication:
28 06 2019
28 06 2019
Historique:
received:
17
11
2018
revised:
07
03
2019
accepted:
09
03
2019
pubmed:
25
3
2019
medline:
27
2
2020
entrez:
25
3
2019
Statut:
ppublish
Résumé
Since metastasis accounts for the majority of cancer-associated deaths, studies on the mechanisms of metastasis are needed to establish innovative strategies for cancer treatment. We previously reported that melanoma cell adhesion molecule (MCAM) functions as a critical receptor for S100A8/A9, and binding of S100A8/A9 to MCAM results in the migration of melanoma cells to lung tissue. However, the critical role of MCAM in the original melanoma skin lesion is still not clear. In this study, we aimed to determine the importance of the S100A8/A9-MCAM axis in melanoma dissemination in a skin lesion as a critical early step for metastasis. Mechanistic studies revealed the downstream signaling of MCAM that signaled the induction of metastasis. S100A8/A9-MCAM binding activates mitogen-activated protein kinase kinase kinase 8 (MAP3K8), also termed TPL2, leading to strong activation of the transcription factor ETV4 and subsequent induction of matrix metalloproteinase-25 (MMP25), and finally to induction of melanoma lung tropic metastasis. Collectively, our results demonstrate a crucial role of the S100A8/A9-MCAM signaling axis in metastatic onset of melanoma cells and indicate that strategies targeting the identified pathway may be useful for the establishment of innovative anti-cancer therapies.
Identifiants
pubmed: 30904617
pii: S0304-3835(19)30179-X
doi: 10.1016/j.canlet.2019.03.023
pii:
doi:
Substances chimiques
CD146 Antigen
0
Calgranulin A
0
Calgranulin B
0
ETV4 protein, human
0
GPI-Linked Proteins
0
MCAM protein, human
0
Proto-Oncogene Proteins
0
Proto-Oncogene Proteins c-ets
0
RNA, Small Interfering
0
S100A8 protein, human
0
S100A9 protein, human
0
MAP Kinase Kinase Kinases
EC 2.7.11.25
MAP3K8 protein, human
EC 2.7.11.25
Matrix Metalloproteinases, Membrane-Associated
EC 3.4.24.-
matrix metalloproteinase 25
EC 3.4.24.-
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
178-190Informations de copyright
Copyright © 2019 The Author(s). Published by Elsevier B.V. All rights reserved.